Y - AcelRx Pharmaceuticals EPS in-line misses on revenue March, 16 2020 07:36 AM Alleghany Corporation AcelRx Pharmaceuticals (NASDAQ:ACRX): Q4 GAAP EPS of -$0.18 in-line.More news on: AcelRx Pharmaceuticals, Inc., Alleghany Corporation, Earnings news and commentary, Healthcare stocks news Read more ...